TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

This study has been completed.

Study NCT00036920 Information provided by National Cancer Institute (NCI)

First Received: May 13, 2002 Last Updated: December 3, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2002 (Final data collection date for primary outcome measure)

Publications:

Henner WD, Figlin RA, Garland LL, et al.: Phase 2 study of TLK286 (GST P1-1 activated glutathione analog) in advanced non-small cell lung cancer (NSCLC). [Abstract] Proceedings of the American Society of Clinical Oncology 21: A-1249, 2002.